专利号:US-10487070-B2 优先权日:2016-04-13 标 题:Process for preparing intermediates useful in the synthesis of antifungal drugs 发明人:BERTOLINI GIORGIO; COLLI CORRADO; SADA MARA; COLOMBO FEDERICA 权利人:OLON SPA; OLSON S P A 摘要:Subject-matter of the invention is a process for preparing intermediates useful in the synthesis of drugs, for example antifungal drugs, such as efinaconazole. Subject-matter of the invention are also such novel synthesis intermediates and the use thereof.
专利号:US-10626102-B2 优先权日:2015-12-30 标题 :Process for the synthesis of efinaconazol 发明人:VERONESE MARTINO; BETTONI PIERGIORGIO; ROLETTO JACOPO; PAISSONI PAOLO 权利人:PROCOS SPA 摘要:Disclosed is a process for the synthesis of efinaconazole (I), starting from 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole and 4-methylenepiperidine, as free base or hydrochloride, in an organic solvent, under anhydrous conditions and in the presence of neutralising agents and reaction-promoting metal species. (1) The process is particularly advantageous because it gives rise to efinaconazole in high yields and purity, and uses little more than the stoichiometric amount of 4-methylenepiperidine, a rather expensive commercially available reagent.
专利号:EP-3091007-A1 优先权日:2015-05-08 标 题 :Process for the preparation of piperidine compounds 发明人:ATTOLINO EMANUELE; RIZZO ELISABETH; ROSSI DAVIDE 权利人:DIPHARMA FRANCIS SRL 摘要:The present invention relates to a process for the preparation of intermediates useful in the synthesis of efinaconazole and their use in the synthesis of efinaconazole.
专利号:US-2023364251-A1 优先权日:2020-08-06 标 题:Methods for the synthesis of protein-drug conjugates 发明人:BORCHARDT ALLEN; HUGHES ROBERT MICHAEL 权利人:CIDARA THERAPEUTICS INC 摘要:The present invention relates to intermediates and methods for synthesizing protein-drug conjugates that can be used for the treatment of diseases and related conditions.
专利号:ES-2785157-T3 优先权日:2016-04-13 标 题 :Procedure for the preparation of useful intermediates in the synthesis of antifungal drugs
专利号:US-2019119244-A1 优先权日:2016-04-13 标 题 :Process for preparing intermediates useful in the synthesis of antifungal drugs
1: Gupta AK, Talukder M. Efinaconazole in Onychomycosis. Am J Clin Dermatol. 2022 Mar;23(2):207-218. doi: 10.1007/s40257-021-00660-1. Epub 2021 Dec 13. 2006–. Efinaconazole. 2018 Dec 3. 30(2):245-255. doi: 10.1177/0897190016630904. Epub 2016 Jul 8. 20(1):3-15. doi: 10.1080/14787210.2021.1939011. Epub 2021 Jun 30. 8:163-72. doi: 10.2147/IDR.S69596. 6: Lipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019 Apr;80(4):853-867. doi: 10.1016/j.jaad.2018.05.1260. Epub 2018 Jun 28. 104(6):568-73. doi: 10.7547/8750-7315-104.6.568. 18(3):151-5. doi: 10.2310/7750.2013.13095. 1(2):107-114. doi: 10.3390/jof1020107.
合成参考文献
摘要:NIH; DailyMed. Current Medication Information for Jublia (Efinaconazole) Solution (Updated: May 2016). Available from, as of July 5, 2016: 参考文献:10.1128/aac.02703-13 摘要:Iwata A, Watanabe Y, Kumagai N, Katafuchi-Nagashima M, Sugiura K, Pillai R, Tatsumi Y. In Vitro and In Vivo Assessment of Dermatophyte Acquired Resistance to Efinaconazole, a Novel Triazole Antifungal. Antimicrob Agents Chemother. 2014 Aug;58(8):4920–2. doi: 10.1128/aac.02703-13. 参考文献:10.1248/yakushi.17-00118-2 摘要:Yoneta Y, Imazu Y, Uchida E, Yamaura K, Suzuki J. [Current Status of Onychomycosis Topical Therapy Conducted at Home]. Yakugaku Zasshi. 2018;138(5):607–9. doi: 10.1248/yakushi.17-00118-2. 参考文献:10.1248/yakushi.17-00118-4 摘要:Yamaura K, Hayashi N, Imazu Y, Yoneta Y, Uchida E, Suzuki J. [Role of Pharmacists in Topical Therapy for Onychomycosis in the Home-care Setting]. Yakugaku Zasshi. 2018;138(5):615–9. doi: 10.1248/yakushi.17-00118-4.